Colon epithelial proliferation and carcinogenesis in diet-induced obesity

Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis

(2011) H. Endo et al.   GUT

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

(2010) K. Hosono et al.   Cancer Prevention Research

Abdominal Visceral Adipose Tissue Predicts Risk of Colorectal Adenoma in Both Sexes

(2010) Su Youn Nam et al.   Clinical Gastroenterology and Hepatology

Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase

(2010) Kunihiro Hosono et al.   MOLECULAR CARCINOGENESIS

PPARγLigand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

(2010) Hirokazu Takahashi et al.   PPAR Research

Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population

(2009) Hirokazu Takahashi et al.   CANCER SCIENCE

New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes

(2009) G. Libby et al.   DIABETES CARE

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Modifiable Risk Factors for Colorectal Neoplasms and Hyperplastic Polyps

(2009) Fumio Omata et al.   INTERNAL MEDICINE

Metformin suppresses intestinal polyp growth in ApcMin/+ mice

(2008) Ayako Tomimoto et al.   CANCER SCIENCE

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

(2008) T Fujisawa et al.   GUT

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE